MEDP
Income statement / Annual
Last year (2024), Medpace Holdings, Inc.'s total revenue was $2.11 B,
an increase of 11.84% from the previous year.
In 2024, Medpace Holdings, Inc.'s net income was $404.39 M.
See Medpace Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$2.11 B |
$1.89 B |
$1.46 B |
$1.14 B |
$925.93 M |
$860.97 M |
$704.59 M |
$436.15 M |
$421.58 M |
$359.06 M |
Cost of Revenue |
$1.45 B
|
$1.36 B
|
$1.03 B
|
$814.22 M
|
$647.20 M
|
$615.27 M
|
$489.06 M
|
$261.46 M
|
$249.47 M
|
$202.67 M
|
Gross Profit |
$656.31 M
|
$524.51 M
|
$432.44 M
|
$328.16 M
|
$278.73 M
|
$245.70 M
|
$215.53 M
|
$174.69 M
|
$172.11 M
|
$156.39 M
|
Gross Profit Ratio |
0.31
|
0.28
|
0.3
|
0.29
|
0.3
|
0.29
|
0.31
|
0.4
|
0.41
|
0.44
|
Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$0.00
|
$159.85 M
|
$130.10 M
|
$107.22 M
|
$91.46 M
|
$94.55 M
|
$75.68 M
|
$63.36 M
|
$61.51 M
|
$56.60 M
|
Selling & Marketing Expenses |
$0.00
|
$1.50 M
|
$1.30 M
|
$1.20 M
|
$700,000.00
|
$700,000.00
|
$800,000.00
|
$600,000.00
|
$600,000.00
|
$400,000.00
|
Selling, General & Administrative Expenses |
$180.18 M
|
$161.35 M
|
$131.40 M
|
$108.42 M
|
$92.16 M
|
$95.25 M
|
$75.68 M
|
$63.36 M
|
$61.51 M
|
$57.00 M
|
Other Expenses |
$29.25 M
|
$26.33 M
|
$22.34 M
|
$21.12 M
|
$19.53 M
|
$23.19 M
|
$1.06 M
|
-$354,000.00
|
-$423,000.00
|
$174,000.00
|
Operating Expenses |
$209.44 M
|
$187.68 M
|
$153.74 M
|
$129.54 M
|
$111.68 M
|
$118.43 M
|
$114.48 M
|
$109.83 M
|
$119.62 M
|
$126.52 M
|
Cost And Expenses |
$1.66 B
|
$1.55 B
|
$1.18 B
|
$943.76 M
|
$758.88 M
|
$733.71 M
|
$603.54 M
|
$371.29 M
|
$369.09 M
|
$329.18 M
|
Interest Income |
$0.00
|
$0.00
|
$2.91 M
|
$105,000.00
|
$307,000.00
|
$1.57 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$488,000.00
|
$2.91 M
|
$105,000.00
|
$307,000.00
|
$1.57 M
|
$8.16 M
|
$7.56 M
|
$19.38 M
|
$27.26 M
|
Depreciation & Amortization |
$0.00
|
$26.33 M
|
$40.36 M
|
$37.41 M
|
$33.45 M
|
$23.19 M
|
$38.80 M
|
$46.47 M
|
$58.11 M
|
$69.52 M
|
EBITDA |
$446.87 M |
$363.15 M |
$301.04 M |
$219.73 M |
$186.57 M |
$150.45 M |
$140.91 M |
$110.98 M |
$110.60 M |
$102.60 M |
EBITDA Ratio |
0.21
|
0.19
|
0.21
|
0.19
|
0.2
|
0.17
|
0.2
|
0.25
|
0.26
|
0.28
|
Operating Income Ratio |
0.21
|
0.18
|
0.19
|
0.17
|
0.18
|
0.15
|
0.14
|
0.17
|
0.14
|
0.1
|
Total Other Income/Expenses Net |
$29.05 M
|
-$1.14 M
|
$4.16 M
|
$3.24 M
|
$1.49 M
|
-$2.43 M
|
-$7.10 M
|
-$7.91 M
|
-$30.53 M
|
-$28.39 M
|
Income Before Tax |
$475.92 M
|
$335.68 M
|
$282.86 M
|
$201.85 M
|
$168.53 M
|
$124.83 M
|
$93.95 M
|
$56.95 M
|
$21.96 M
|
-$7.83 M
|
Income Before Tax Ratio |
0.23
|
0.18
|
0.19
|
0.18
|
0.18
|
0.14
|
0.13
|
0.15
|
0.06
|
-0.02
|
Income Tax Expense |
$71.54 M
|
$52.87 M
|
$37.49 M
|
$20.00 M
|
$23.15 M
|
$24.39 M
|
$20.77 M
|
$17.82 M
|
$8.53 M
|
$843,000.00
|
Net Income |
$404.39 M
|
$282.81 M
|
$245.21 M
|
$181.39 M
|
$144.93 M
|
$100.16 M
|
$72.89 M
|
$39.03 M
|
$13.39 M
|
-$8.67 M
|
Net Income Ratio |
0.19
|
0.15
|
0.17
|
0.16
|
0.16
|
0.12
|
0.1
|
0.1
|
0.04
|
-0.03
|
EPS |
13.06 |
9.2 |
7.57 |
5.06 |
4.07 |
2.79 |
2.05 |
1 |
0.38 |
-0.28 |
EPS Diluted |
12.63 |
8.88 |
7.28 |
4.81 |
3.84 |
2.67 |
1.97 |
0.98 |
0.37 |
-0.28 |
Weighted Average Shares Out |
$30.96 M
|
$30.72 M
|
$32.39 M
|
$35.86 M
|
$35.64 M
|
$35.88 M
|
$35.55 M
|
$39.06 M
|
$35.69 M
|
$39.63 M
|
Weighted Average Shares Out Diluted |
$32.01 M
|
$31.84 M
|
$33.67 M
|
$37.70 M
|
$37.71 M
|
$37.58 M
|
$36.91 M
|
$39.84 M
|
$36.33 M
|
$39.63 M
|
Link |
|
|
|
|
|
|
|
|
|
|